This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2023!
8-11 May 2023RAI in Amsterdam

Hemant Dhamne, Remote
Head, Process Development, Gene Therapy Vector Facility at King's College London, UK


Hemant Dhamne is an expert in the field of cell and gene therapy with specific experience in building and operating Product, Process, Analytical Development, and Manufacturing functions.

He has done a Ph.D. in Viral Vectors/Gene Therapy followed by a Post Doc in Functional Genomics. Later he has worked with Intas Pharmaceuticals for AAV Gene Therapy and most recently with Immuneel Therapeutics for CAR-T cell therapy. He also holds a diploma in International Business and Medical Diagnostics. At present, he is heading the Process Development of Gene Therapy at an organization in London.

He has led the team delivering pre-IND & IND applications for AAV-8 FIX, AAV8-FVIII, and CD19-CAR T products. He built the capability and infrastructure for cell and gene therapy in India and was the key person to bring the CGT wave to his country.

Besides this, Hemant also indulges in Indian classical music, learning vocals and bamboo flute.

Agenda Sessions

  • CGT Process Development - Challenges and Avenues

  • Diversity, Equity & Inclusion Coffee Morning

  • Panel Discussion: Future Outlook for Gene Therapy - mRNA vs Viral Vectors